Aristotle University Of Thessaloniki (AUTH)
Αναζήτηση βιοδεικτών εξέλιξης της νόσου σε ενήλικες ασθενείς με νωτιαία μυϊκή ατροφία: προοπτική μελέτη παρατήρησης τύπου ασθενών-μαρτύρων
Abstract
dc:descriptionSpinal muscular atrophy (SMA) is a genetic disorder characterized by lower motor neuron degeneration. The rapid expansion of clinical trials in SMA has led to the approval of three disease-modifying therapies. Despite these therapeutic advances, available clinical biomarkers have limited sensitivity for detecting subtle changes expected in patients with longer disease duration. The aim of this prospective observational study was to explore potential reliable and valid biomarkers for monitoring adult SMA patients (≥16 years) over an 18-month period. The primary endpoint was the comparison of motor unit number estimation (MUNE) using the MScanFit MUNE method between SMA adults and healthy controls (HCs). In addition, the reliability of MScanFit MUNE was assessed, complement activation was compared between the two groups, and changes in neurophysiological and molecular biomarkers over 18 months were evaluated, along with their associations with established clinical assessment scales. Statistical analyses included cross-sectional comparisons and longitudinal within subject and between groups analyses. Twenty-two consecutive SMA patients aged ≥16 years and 22 sex- and age-matched HCs were recruited (mean age 36 years, p=0.9). Cross-sectional analysis demonstrated significant differences in MScanFit MUNE parameters between SMA patients and HCs (p<0.001). MScanFit MUNE presented excellent diagnostic ability with first dorsal interosseous (FDI) achieving the highest area under the curve (AUC=1). MScanFit MUNE also differed significantly across SMA subtypes (p≤0.01) and functional levels (p≤0.002), while ambulation status was identified as an independent predictor of MScanFit MUNE (p<0.05). Strong positive correlations with most clinical parameters (Spearman’s ρ≥0.8, p<0.001) were detected. Abductor pollicis brevis (APB) MScanFit MUNE measurements demonstrated excellent reliability (ICC=0.97). SMA patients had higher serum C3 (p=0.04) and lower C1q levels (p=0.02) compared with HCs, whereas no statistically significant differences were observed in serum sC5b-9 and C4 levels between the two groups. No significant correlations were identified between complement activation parameters and clinical scales. Statistically significant changes in FDI, ADM and the sum of the examined muscles (SUM) MScanFit MUNE values were observed over 18 months among SMA adults, in contrast to HCs. Similarly, statistically significant differences in MScanFit MUNE FDI (p=0.04) and SUM (p=0.002) change over 18 months were found between the two groups. C1q levels decreased significantly (p=0.04), while sC5b-9 levels also changed significantly (p=0.01) in SMA patients over follow-up; however, complement activation longitudinal changes did not differ significantly between groups. This prospective study is the largest study to date evaluating MScanFit MUNE in 22 SMA adults with the longest follow-up period. These findings support MScanFit MUNE use as a reliable and valid diagnostic and monitoring biomarker of disease progression in SMA adults. Although complement activity was affected in adults with SMA, further studies are needed to elucidate its contribution to the pathophysiological mechanisms underlying different SMA types. Given the substantial heterogeneity and slow disease progression in SMA adults, the integration of multiple complementary biomarkers into a multifactorial biomarker toolbox may, in future multicenter studies, enable a more comprehensive understanding of disease progression and therapeutic response, potentially leading to the development of personalized approaches to SMA management.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gavriilaki, Maria
- Γαβριηλάκη, Μαρία
Subjects
dc:subject × 14- Νωτιαία μυϊκή ατροφία
- Βιοδείκτες
- Εκτίμηση του αριθμού των κινητικών μονάδων
- Σύστημα συμπληρώματος
- Spinal muscular atrophy
- Biomarkers
- Motor unit number estimation
- Complement activation
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική νευρολογία
- Clinical Medicine
- Medical and Health Sciences
- Clinical Neurology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62136